Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
20.92
-0.33 (-1.55%)
Sep 29, 2026, 4:00 PM EDT - Market closed
Pelthos Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 24.19 | 17.97 | 0.51 | 0.1 | 0.06 | - |
Cash & Short-Term Investments | 24.19 | 17.97 | 0.51 | 0.1 | 0.06 | - |
Cash Growth | 40784.20% | 3403.51% | 432.21% | 75.02% | - | - |
Receivables | 14.48 | 8.86 | - | - | - | - |
Inventory | 21.47 | 23.57 | - | - | - | - |
Prepaid Expenses | 0.5 | 1.21 | - | - | - | - |
Restricted Cash | 0.37 | 0.05 | - | - | - | - |
Other Current Assets | 2.35 | 1.75 | 0.86 | - | - | - |
Total Current Assets | 63.36 | 53.41 | 1.37 | 0.1 | 0.06 | - |
Property, Plant & Equipment | 11.92 | 12.84 | - | - | - | - |
Goodwill | 24.68 | 24.68 | - | - | - | - |
Other Intangible Assets | 37.4 | 39.47 | - | - | - | - |
Total Assets | 137.36 | 130.4 | 1.37 | 0.1 | 0.06 | - |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 5.85 | 2.99 | 1.9 | 4.62 | 2.99 | 2.58 |
Accrued Expenses | 20.75 | 15.36 | - | 0.65 | 0.22 | - |
Short-Term Debt | - | - | 2.19 | 1.27 | 0.54 | - |
Current Portion of Leases | 0.65 | 0.64 | - | - | - | - |
Current Unearned Revenue | 0.73 | 0.97 | - | - | - | - |
Other Current Liabilities | 3.99 | 6.04 | - | 0.01 | 0.01 | - |
Total Current Liabilities | 31.96 | 25.99 | 4.08 | 6.54 | 3.76 | 2.58 |
Long-Term Debt | 69.91 | 31.44 | - | - | - | 1.1 |
Long-Term Leases | 2.55 | 2.75 | - | - | - | - |
Long-Term Unearned Revenue | 1.09 | 1.28 | - | - | - | - |
Other Long-Term Liabilities | 33.34 | 30.05 | - | - | - | - |
Total Liabilities | 138.86 | 91.52 | 4.08 | 6.54 | 3.76 | 3.68 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | - | - | - | 0 | 0 | - |
Additional Paid-In Capital | 109.71 | 103.68 | 18.76 | 7.07 | 2.43 | - |
Retained Earnings | -113.28 | -64.79 | -21.48 | -13.52 | -6.14 | -3.68 |
Total Common Equity | -1.5 | 38.88 | -2.71 | -6.44 | -3.71 | -3.68 |
Shareholders' Equity | -1.5 | 38.88 | -2.71 | -6.44 | -3.71 | -3.68 |
Total Liabilities & Equity | 137.36 | 130.4 | 1.37 | 0.1 | 0.06 | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 73.11 | 34.83 | 2.19 | 1.27 | 0.54 | 1.1 |
Net Cash (Debt) | -48.92 | -16.86 | -1.67 | -1.17 | -0.49 | -1.1 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -14.93 | -8.96 | -3.00 | -9.18 | -11.15 | - |
Filing Date Shares Outstanding | 3.83 | 3.36 | 0.61 | 0.59 | 0.11 | - |
Total Common Shares Outstanding | 3.72 | 3.23 | 0.61 | 0.39 | 0.11 | - |
Working Capital | 31.4 | 27.42 | -2.71 | -6.44 | -3.71 | -2.58 |
Book Value Per Share | -0.40 | 12.02 | -4.45 | -16.46 | -33.36 | - |
Tangible Book Value | -63.58 | -25.27 | -2.71 | -6.44 | -3.71 | -3.68 |
Tangible Book Value Per Share | -17.10 | -7.81 | -4.45 | -16.46 | -33.36 | - |
Machinery | 2.16 | 1.96 | - | - | - | - |
Construction In Progress | 1.52 | 1.51 | - | - | - | - |
Leasehold Improvements | 5.99 | 5.97 | - | - | - | - |